Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
They are the ones to read carefully
Popular brands of these anti-diabetes and anti-obesity drugs include Ozempic, Wegovy and Mounjaro
If lower-cost versions of GLP-1 therapies enter the market, healthcare organizations may gain more flexibility in expanding treatment access
The race to generics and alternatives Novo Nordisks first GLP-1 drug liraglutide will be off patent in November and in June Teva Pharmaceuticals received US authorisation to market the first-ever generic version, to treat diabetes
US$ 21.84
US$ 23.20
US$ 21.22
US$ 27.62
US$ 28.75
